Latigo Biotherapeutics Inc (LTGO)

Latigo Biotherapeutics Inc recorded significant insider activity on August 10, 2026. Foresite Capital Management V, LLC and James B. Tananbaum each purchased 140,000 shares, totaling 2.52 million dollars per transaction. These acquisitions represent the most recent documented trades, occurring over three months ago, preceding the company's latest results financiers.
Ticker: LTGO


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
281.28
Quantity 76,382 -49.2%
Value US$445,772
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-10 2026-08-10 B Purchase Large shareholder
89,627 -39.0%
471.30
US$972,291
89,627 -39.0% 471.30 US$972,291
2026-08-10 2026-08-10 B Purchase Non-Executive Director Large shareholder
76,382 -49.2%
281.28
US$445,772
76,382 -49.2% 281.28 US$445,772